Preparation of poly(ethylene glycol) protected nanoparticles with variable bioconjugate ligand density.
about
Flash nanoprecipitation: particle structure and stability.Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticlesAmphiphilic nanoparticles repress macrophage atherogenesis: novel core/shell designs for scavenger receptor targeting and down-regulation.Maleimide Functionalized Poly(ε-caprolactone)-b-poly(ethylene glycol) (PCL-PEG-MAL): Synthesis, Nanoparticle Formation, and Thiol Conjugation.Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides.Quantitative comparison of tumor delivery for multiple targeted nanoparticles simultaneously by multiplex ICP-MSModulating Vibrio cholerae quorum-sensing-controlled communication using autoinducer-loaded nanoparticlesSynthetic Strategies for Engineering Intravenous Hemostats.Review of Long-Wavelength Optical and NIR Imaging Materials: Contrast Agents, Fluorophores and Multifunctional Nano CarriersControl of polymeric nanoparticle size to improve therapeutic delivery.In vitro controlled release of antigen in dendritic cells using pH-sensitive liposome-polymeric hybrid nanoparticles.Polymer directed self-assembly of pH-responsive antioxidant nanoparticlesKinetically assembled nanoparticles of bioactive macromolecules exhibit enhanced stability and cell-targeted biological efficacyEffect of ligand density, receptor density, and nanoparticle size on cell targetingOptimization of cell receptor-specific targeting through multivalent surface decoration of polymeric nanocarriers.Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy.Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy.Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.Novel methods of targeted drug delivery: the potential of multifunctional nanoparticles.Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry.Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles.Controlling ligand surface density optimizes nanoparticle binding to ICAM-1.Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma.Microfluidic Assembly of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantane Host:Guest pDNA Nanoparticles.Preparation of stable maleimide-functionalized au nanoparticles and their use in counting surface ligands.Continuous Production of Discrete Plasmid DNA-Polycation Nanoparticles Using Flash Nanocomplexation.A molecular Fe-complex as a catalyst probe for in-gel visual detection of proteins via signal amplification.Thiol-ene “click” reactions and recent applications in polymer and materials synthesisProgress of Nanobiomaterials for Theranostic SystemsThe Chemistry of Bioconjugation in Nanoparticles-Based Drug Delivery System
P2860
Q30668553-361476E8-B6E6-405A-82A9-488BF6125A23Q33624748-5475892B-25F7-4F09-89A2-402260BC9C4BQ34089117-9E75376D-BCE6-49DC-958C-EDBC0A6F91ADQ35083235-A9110CC6-7E73-471C-A0B1-FFB8F87A68DCQ35087556-153EFC4A-E319-499F-B2E1-302BFBDABA2EQ35214069-696DDD52-906B-4EA7-BEA5-0298B5542B35Q35328795-B373FC42-66B1-4EF0-9AA6-27E6700DFD57Q35858739-84696260-4ABC-4B10-BEB8-BAFB3E198EC7Q36176439-54A65ADB-534D-4BD1-A1C6-A7F516181C65Q36307555-EFDBF7FE-5152-4EDB-9330-2E251B3E4FDDQ36326918-489FC022-682B-4EFB-8C04-5AAD9F72377AQ36372387-9C27F7A8-4AB1-4BDA-9123-DC06A6DA83D7Q36390180-1E65845B-2ADC-4516-9227-7AD15067BEF7Q36413263-8130626B-C0CD-47B4-9676-4C7FC3915AF4Q36869824-CD52C7B5-5AFD-42DE-A278-23B25B9AF839Q37564506-0B76038B-6845-4886-A03D-E557E608510BQ37978315-911FF65E-9DBC-4654-AE49-0474CA365A34Q38067265-BD2B4C1E-A628-42C2-AF57-F95E4830E08BQ38177370-88F7C983-0EFB-455D-823F-0987F0074D1AQ38736346-F47675B8-89CA-4DA8-B652-B05F4C65B3F0Q38883410-99A99B2A-75D7-4843-B847-BF086AA756F4Q39648047-975428F0-2943-4A82-AE8B-2E1ABE21D317Q42579276-31EE247E-4F77-4BBE-AA72-BD3B16FF623AQ42818425-0585D14E-6E37-41B9-A18A-35BF95D9E057Q43058839-F1A45A1C-A10E-4D35-A7F4-95601A283115Q45346878-C969410C-B76C-4E48-B857-A4935A5B0FAFQ53182904-FE0B3520-B53D-4234-9EB9-E675E357DBF2Q54279480-59E26CBA-2B37-434E-9398-7A52B8AE51E3Q57341103-5C954E57-099B-4935-8D20-568D8B280E0FQ59101713-541CB759-73A4-45D2-8E3F-B82233848BCF
P2860
Preparation of poly(ethylene glycol) protected nanoparticles with variable bioconjugate ligand density.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Preparation of poly(ethylene g ...... e bioconjugate ligand density.
@en
type
label
Preparation of poly(ethylene g ...... e bioconjugate ligand density.
@en
prefLabel
Preparation of poly(ethylene g ...... e bioconjugate ligand density.
@en
P2093
P356
P1433
P1476
Preparation of poly(ethylene g ...... e bioconjugate ligand density.
@en
P2093
Marian E Gindy
Robert K Prud'homme
Shengxiang Ji
Thomas R Hoye
P304
P356
10.1021/BM8002013
P577
2008-08-30T00:00:00Z